RE-BVS – Piemonte Repository

Sfoglia per AUTORE
GARRONE O
Collezione ASL Torino 4

Items : 3

Codon-specific KRAS mutations predict survival benefit of trifluridine/tipiracil in metastatic colorectal cancer. in Nature medicine / Nat Med. 2023 Mar;29(3):605-614. doi: 10.1038/s41591-023-02240-8. Epub 2023 Mar 2.

2023
ASL Torino 4

van de Haar J; Ma X; Ooft SN; van der Helm PW; Hoes LR; Mainardi S; Pinato DJ; Sun K; Salvatore L; Tortora G; Zurlo IV; Leo S; Giampieri R; Berardi R; Gelsomino F; Merz V; Mazzuca F; Antonuzzo L; Rosati G; Stavraka C; Ross P; Rodriquenz MG; Pavarana M; Messina C; Iveson T; Zoratto F; Thomas A; Fenocchio E; Ratti M; et alii...

Conversion Strategy in Left-Sided RAS/BRAF Wild-Type Metastatic Colorectal Cancer Patients with Unresectable Liver-Limited Disease: A Multicenter Cohort Study. in Cancers / Cancers (Basel). 2022 Nov 9;14(22):5513. doi: 10.3390/cancers14225513.

2022
ASL Torino 4
AOU Città della Salute di Torino

Garrone O; Facciorusso A; Memeo R; de Angelis N; Germini A; Gjoni E; Roberto M; De Tursi M; Morelli C; Berardi R; Giampieri R; Depetris I; Zurlo IV; Gelsomino F; Nigro O; Filippi R; Salvatore L; Bonomi A; Cotsoglou C; Granieri S; Ramai D; Ghidini M; Parisi A;

Primary versus secondary antiemetic prophylaxis with NK1 receptor antagonists in patients affected by gastrointestinal malignancies and treated with a doublet or triplet combination regimen including oxaliplatin and/or irinotecan plus fluoropyrimidines: A propensity score matched analysis. in Frontiers in oncology / Front Oncol. 2022 Aug 12;12:935826. doi: 10.3389/fonc.2022.935826. eCollection 2022.

2022
ASL Torino 4
AOU Città della Salute di Torino

Berardi R; Galassi B; Ferri C; Garrone O; Zoratto F; Ciardiello D; Pensieri MV; Tomao S; Depetris I; Di Pietro FR; Dell'Aquila E; Giordano G; Landriscina M; Vitale P; Zurlo IV; De Tursi M; Di Marino P; Daniele B; Satolli MA; Petrillo A; Strippoli A; Filippi R; Bensi M; Maratta MG; Salvatore L; Ghidini M; Felicetti C; Giampieri R; Mammarella A; et alii...